# A Study to Evaluate Food Effect on ONO-5920/YM529 Intermittent Formulation

> **NCT00965978** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 48 (actual)

## Conditions studied

- Osteoporosis
- Osteoporosis, Postmenopausal
- Bone Diseases

## Interventions

- **DRUG:** ONO-5920 / YM529

## Key facts

- **NCT ID:** NCT00965978
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2009-10-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00965978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00965978, "A Study to Evaluate Food Effect on ONO-5920/YM529 Intermittent Formulation". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00965978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*